Literature DB >> 10811149

Longitudinal course of behavioral problems during Alzheimer's disease: linear versus curvilinear patterns of decline.

H J McCarty1, D L Roth, K T Goode, J E Owen, L Harrell, K Donovan, W E Haley.   

Abstract

BACKGROUND: Patients with Alzheimer's Disease (AD) are commonly assumed to experience a linear decline in behavioral functioning that parallels progressive cognitive decline. However, some researchers have suggested that specific behavioral problems either decline at different rates or improve in late dementia.
METHODS: The present analyses examined 150 AD patients at an initial assessment, 61 of whom were also evaluated annually on two additional occasions. Measures of cognitive impairment and behavioral problems were obtained.
RESULTS: Cross-sectional results indicated curvilinear associations between dementia severity and certain behavioral problems (forgetful behaviors, and emotional and impulsive behaviors). Longitudinal analyses further indicated trends for curvilinear rates of behavioral disturbance across time, with some problem areas showing improvement as AD progresses through the most severe stages.
CONCLUSIONS: Even though Alzheimer's disease is a progressive dementia characterized by increasing cognitive deterioration, it appears to be inaccurate to expect behavioral functioning to show the same linear decline across time.

Entities:  

Mesh:

Year:  2000        PMID: 10811149     DOI: 10.1093/gerona/55.4.m200

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  8 in total

1.  Psychometric analysis of the Revised Memory and Behavior Problems Checklist: factor structure of occurrence and reaction ratings.

Authors:  David L Roth; Louis D Burgio; Laura N Gitlin; Dolores Gallagher-Thompson; David W Coon; Steven H Belle; Alan B Stevens; Robert Burns
Journal:  Psychol Aging       Date:  2003-12

2.  Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Authors:  Pierre N Tariot; Lon S Schneider; Jeffrey Cummings; Ronald G Thomas; Rema Raman; Laura J Jakimovich; Rebekah Loy; Barbara Bartocci; Adam Fleisher; M Saleem Ismail; Anton Porsteinsson; Michael Weiner; Clifford R Jack; Leon Thal; Paul S Aisen
Journal:  Arch Gen Psychiatry       Date:  2011-08

3.  Health trajectories of family caregivers: associations with care transitions and adult day service use.

Authors:  Yin Liu; Kyungmin Kim; Steven H Zarit
Journal:  J Aging Health       Date:  2014-10-27

4.  End-of Life Issues in the Context of Alzheimer's Disease.

Authors:  Rebecca S Allen; Jung Kwak; Kristine L Lokken; William E Haley
Journal:  Alzheimers Care Q       Date:  2003-10-01

5.  Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Jeffrey L Cummings; Marian B Patterson; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

6.  Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.

Authors:  Xiangpei Yue; Yanzhao Zhou; Meng Qiao; Xingnan Zhao; Xin Huang; Tong Zhao; Xiang Cheng; Ming Fan; Yongqi Zhao; Ruoli Chen; Lingling Zhu
Journal:  Alzheimers Res Ther       Date:  2021-11-29       Impact factor: 6.982

7.  A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: design and methods of project ACT3.

Authors:  Laura N Gitlin; Laraine Winter; Marie P Dennis; Walter W Hauck
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 8.  Longitudinal course of behavioural and psychological symptoms of dementia: systematic review.

Authors:  Rianne M van der Linde; Tom Dening; Blossom C M Stephan; A Matthew Prina; Elizabeth Evans; Carol Brayne
Journal:  Br J Psychiatry       Date:  2016-08-04       Impact factor: 9.319

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.